Filtered By:
Vaccination: Measles Vaccine
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 1239 results found since Jan 2013.
Viral vectors engineered for gene therapy
Int Rev Cell Mol Biol. 2023;379:1-41. doi: 10.1016/bs.ircmb.2023.05.005. Epub 2023 Jul 1.ABSTRACTGene therapy has seen major progress in recent years. Viral vectors have made a significant contribution through efficient engineering for improved delivery and safety. A large variety of indications such as cancer, cardiovascular, metabolic, hematological, neurological, muscular, ophthalmological, infectious diseases, and immunodeficiency have been targeted. Viral vectors based on adenoviruses, adeno-associated viruses, herpes simplex viruses, retroviruses including lentiviruses, alphaviruses, flaviviruses, measles viruses, rh...
Source: International Review of Cell and Molecular Biology - August 4, 2023 Category: Cytology Authors: Kenneth Lundstrom Source Type: research
Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030
Vaccine. 2023 Aug 1:S0264-410X(23)00854-X. doi: 10.1016/j.vaccine.2023.07.033. Online ahead of print.ABSTRACTBACKGROUND: The Immunization Agenda 2030 (IA2030) Impact Goal 1.1. aims to reduce the number of future deaths averted through immunization in the next decade. To estimate the potential impact of the aspirational coverage targets for IA2030, we developed an analytical framework and estimated the number of deaths averted due to an ambitious vaccination coverage scenario from 2021 to 2030 in 194 countries.METHOD: A demographic model was used to determine annual age-specific mortality estimates associated with vaccine c...
Source: Vaccine - August 3, 2023 Category: Allergy & Immunology Authors: Austin Carter William Msemburi So Yoon Sim Katy A M Gaythorpe Philipp Lambach Ann Lindstrand Raymond Hutubessy Source Type: research
Long-term immunoprotection after live attenuated measles-mumps-rubella booster vaccination in children with juvenile idiopathic arthritis
CONCLUSION: The MMR booster vaccine demonstrated long-term immunogenicity in the majority of children with JIA from a large cohort, although lower percentages of protective measles antibody levels were observed in bDMARD users. Hence, it might be indicated to measure antibody levels at least five years after MMR booster vaccination in the latter group and advice an extra booster accordingly.PMID:37516575 | DOI:10.1016/j.vaccine.2023.07.052
Source: Vaccine - July 29, 2023 Category: Allergy & Immunology Authors: Mohamad Hamad Saied Joeri W van Straalen Sytze de Roock Gerrie C J de Joode-Smink Frans M Verduyn Lunel Joost F Swart Nico M Wulffraat Marc H A Jansen Source Type: research
Measles and Varicella Vaccination Program in a Hospital: Implementation and Impact on Contact Tracing
This study aims to describe the implementation process of a measles and varicella vaccination program and report on the reduction in the number of susceptible healthcare workers exposed to measles, varicella, and disseminated herpes zoster at a tertiary hospital. The Consolidated Framework for Implementation Research (CFIR) model was used to describe the vaccination program implemented from October 2015 to September 2018. The number of exposed, reviewed, and susceptible healthcare workers during contact tracing for exposure to (a) measles and (b) varicella and disseminated herpes zoster in 2016, 2017, and 2018 is reported....
Source: Herpes - July 29, 2023 Category: Infectious Diseases Authors: Alicia Siew Ting Loi Revathi Sridhar See Ming Lim Source Type: research
Response to Vaccine-Derived Polioviruses Detected through Environmental Surveillance, Guatemala, 2019
Emerg Infect Dis. 2023 Aug;29(8):1524-1530. doi: 10.3201/eid2908.230236.ABSTRACTGuatemala implemented wastewater-based poliovirus surveillance in 2018, and three genetically unrelated vaccine-derived polioviruses (VDPVs) were detected in 2019. The Ministry of Health (MoH) response included event investigation through institutional and community retrospective case searches for acute flaccid paralysis (AFP) during 2018-2020 and a bivalent oral polio/measles, mumps, and rubella vaccination campaign in September 2019. This response was reviewed by an international expert team in July 2021. During the campaign, 93% of children ...
Source: Emerging Infectious Diseases - July 24, 2023 Category: Infectious Diseases Authors: Rodrigo Rodr íguez Elisa Ju árez Concepci ón F Estívariz Coralia Cajas Gloria Rey-Benito Mar ía Olga Bautista Amézquita Stacey Jeffries Miles Oscar Orantes Mar ía Cecilia Freire Ana-Elena Ch évez Leticia Castillo Signor Leanna Sayyad Claudia Jarqu Source Type: research
For the return of high vaccination coverage
This article describes the Project for the Regaining of the High Vaccination Coverage (PRCV) and the strategy of working at the frontline, conducted in the local level, which has been implemented since 2021 and is already starting to show promising results. The PRCV was organized in three thematic axes with shared and specific actions, including: vaccination; information systems; communication and education. The outcomes achieved allow us to affirm that it is possible to reverse the low vaccination coverage, based on the articulation of structural and interinstitutional actions, with the strengthening of public policies an...
Source: Cadernos de Saude Publica - July 21, 2023 Category: International Medicine & Public Health Authors: Akira Homma Maria de Lourdes de Sousa Maia Isabel Cristina Alencar de Azevedo Isabella Lira Figueiredo Luciano Bezerra Gomes Clebson Ver íssimo da Costa Pereira Eliana de F átima Paulo Daniel Bruschi Cardoso Source Type: research
